These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29872577)

  • 1. NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8
    Li L; Han L; Sun F; Zhou J; Ohaegbulam KC; Tang X; Zang X; Steinbrecher KA; Qu Z; Xiao G
    Oncoimmunology; 2018; 7(6):e1435250. PubMed ID: 29872577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-expressed immune checkpoint B7x promotes cancer progression and antigen-specific CD8 T cell exhaustion and suppressive innate immune cells.
    Ohaegbulam KC; Liu W; Jeon H; Almo SC; Zang X
    Oncotarget; 2017 Oct; 8(47):82740-82753. PubMed ID: 29137299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion.
    Li K; Wei L; Huang Y; Wu Y; Su M; Pang X; Wang N; Ji F; Zhong C; Chen T
    Int J Oncol; 2016 Jun; 48(6):2479-87. PubMed ID: 27082857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycocalyx-Mimicking Nanoparticles Improve Anti-PD-L1 Cancer Immunotherapy through Reversion of Tumor-Associated Macrophages.
    Zhang Y; Wu L; Li Z; Zhang W; Luo F; Chu Y; Chen G
    Biomacromolecules; 2018 Jun; 19(6):2098-2108. PubMed ID: 29634251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In adenovirus type 12 tumorigenic cells, major histocompatibility complex class I transcription shutoff is overcome by induction of NF-kappaB and relief of COUP-TFII repression.
    Hou S; Guan H; Ricciardi RP
    J Virol; 2002 Apr; 76(7):3212-20. PubMed ID: 11884545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-κB signalling.
    Xiong HY; Ma TT; Wu BT; Lin Y; Tu ZG
    Asian Pac J Cancer Prev; 2014; 15(14):5767-72. PubMed ID: 25081699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphyllin I Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response in Macrophages Through the NF-κB Pathway.
    Wang Q; Zhou X; Zhao Y; Xiao J; Lu Y; Shi Q; Wang Y; Wang H; Liang Q
    Front Immunol; 2018; 9():2091. PubMed ID: 30319603
    [No Abstract]   [Full Text] [Related]  

  • 10. Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies.
    Liu Y; Liang S; Jiang D; Gao T; Fang Y; Fu S; Guan L; Zhang Z; Mu W; Chu Q; Liu Y; Zhang N
    J Control Release; 2021 Aug; 336():621-634. PubMed ID: 34246701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory effect of SOCS on NF-kappaB activity in murine monocytes/macrophages.
    Park SH; Kim KE; Hwang HY; Kim TY
    DNA Cell Biol; 2003 Feb; 22(2):131-9. PubMed ID: 12713738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
    Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
    Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.
    Kunkl M; Mastrogiovanni M; Porciello N; Caristi S; Monteleone E; Arcieri S; Tuosto L
    Front Immunol; 2019; 10():864. PubMed ID: 31068940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages (TAMs) depend on Shp2 for their anti-tumor roles in colorectal cancer.
    Wang S; Yao Y; Li H; Zheng G; Lu S; Chen W
    Am J Cancer Res; 2019; 9(9):1957-1969. PubMed ID: 31598397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
    Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA
    J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB RelA is a cell-intrinsic metabolic checkpoint restricting glycolysis.
    Li L; Han L; Qu Z
    Cell Biosci; 2024 Jan; 14(1):11. PubMed ID: 38245770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of antisense RelA p65 and NF-kappaB1 p50 oligonucleotides on the nuclear factor-kappaB mediated expression of ICAM-1 in human coronary endothelial and smooth muscle cells.
    Voisard R; Huber N; Baur R; Susa M; Ickrath O; Both A; Koenig W; Hombach V
    BMC Mol Biol; 2001; 2():7. PubMed ID: 11532196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential targeting of B7-H4 for the treatment of cancer.
    Podojil JR; Miller SD
    Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.